Skip to content

Research & Literature

Last updated:

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature

Visualize citation networks across 72 referenced papers

Top Authors

Top Institutions

References

  1. 1

    MELAS syndrome: Clinical manifestations, pathogenesis, and treatment options.

    El-Hattab AW, Adesina AM, Jones J, Scaglia F

    Molecular genetics and metabolism 2015; (116(1-2)):4-12.

    PMID: 26095523
  2. 2

    Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS): A Case Report and Critical Reappraisal of Treatment Options.

    Fryer RH, Bain JM, De Vivo DC

    Pediatric neurology 2016; (56()):59-61 doi:10.1016/j.pediatrneurol.2015.12.010.

    PMID: 26797286
  3. 3

    Impaired nitric oxide production in children with MELAS syndrome and the effect of arginine and citrulline supplementation.

    El-Hattab AW, Emrick LT, Hsu JW, et al.

    Molecular genetics and metabolism 2016; (117(4)):407-12.

    PMID: 26851065
  4. 4

    Application of molecular imaging combined with genetic screening in diagnosing MELAS, diabetes and recurrent pancreatitis.

    Zhiping W, Quwen L, Hai Z, et al.

    Folia neuropathologica 2016; (54(1)):66-71 doi:10.5114/fn.2016.58917.

    PMID: 27179223
  5. 5

    Epilepsy Characteristics and Clinical Outcome in Patients With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS).

    Lee HN, Eom S, Kim SH, et al.

    Pediatric neurology 2016; (64()):59-65 doi:10.1016/j.pediatrneurol.2016.08.016.

    PMID: 27671241
  6. 6

    MELAS Syndrome and Kidney Disease Without Fanconi Syndrome or Proteinuria: A Case Report.

    Rudnicki M, Mayr JA, Zschocke J, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2016; (68(6)):949-953 doi:10.1053/j.ajkd.2016.06.027.

    PMID: 27683045
  7. 7

    The addition of ketone bodies alleviates mitochondrial dysfunction by restoring complex I assembly in a MELAS cellular model.

    Frey S, Geffroy G, Desquiret-Dumas V, et al.

    Biochimica et biophysica acta. Molecular basis of disease 2017; (1863(1)):284-291 doi:10.1016/j.bbadis.2016.10.028.

    PMID: 27815040
  8. 8

    Mitochondrial cytopathy with common MELAS mutation presenting as multiple system atrophy mimic.

    Pröbstel AK, Schaller A, Lieb J, et al.

    Neurology. Genetics 2016; (2(6)):e121 doi:10.1212/NXG.0000000000000121.

    PMID: 27878137
  9. 9

    MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach.

    Seitun S, Massobrio L, Rubegni A, et al.

    Case reports in cardiology 2016; (2016()):1490181 doi:10.1155/2016/1490181.

    PMID: 27891257
  10. 10

    Migratory stroke-like lesions in a case of adult-onset mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome and a review of imaging findings.

    Cai SS, von Coelln R, Kouo TJ

    Radiology case reports 2016; (11(4)):425-429 doi:10.1016/j.radcr.2016.09.003.

    PMID: 27920873
  11. 11

    Assessment of Nitric Oxide Production in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome with the Use of a Stable Isotope Tracer Infusion Technique.

    El-Hattab AW, Jahoor F

    The Journal of nutrition 2017; (147(7)):1251-1257 doi:10.3945/jn.117.248435.

    PMID: 28515163
  12. 12

    Intramyocellular lipid excess in the mitochondrial disorder MELAS: MRS determination at 7T.

    Golla S, Ren J, Malloy CR, Pascual JM

    Neurology. Genetics 2017; (3(3)):e160 doi:10.1212/NXG.0000000000000160.

    PMID: 28589178
  13. 13

    Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses.

    Kuno T, Imaeda S, Asakawa Y, et al.

    Case reports in cardiology 2017; (2017()):9473917 doi:10.1155/2017/9473917.

    PMID: 28620551
  14. 14

    Arginine and citrulline for the treatment of MELAS syndrome.

    El-Hattab AW, Almannai M, Scaglia F

    Journal of inborn errors of metabolism and screening 2017; (5()) doi:10.1177/2326409817697399.

    PMID: 28736735
  15. 15

    MELAS and Kearns-Sayre overlap syndrome due to the mtDNA m. A3243G mutation and large-scale mtDNA deletions.

    Yu N, Zhang YF, Zhang K, et al.

    eNeurologicalSci 2016; (4()):15-18 doi:10.1016/j.ensci.2016.04.006.

    PMID: 29430542
  16. 16

    mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease.

    Grady JP, Pickett SJ, Ng YS, et al.

    EMBO molecular medicine 2018; (10(6)) doi:10.15252/emmm.201708262.

    PMID: 29735722
  17. 17

    Simultaneous 18F-FDG PET/MRI Assists Diagnosis of a Rare Disease, MELAS.

    Liu F, Ruan W, Wang Y, Lan X

    Clinical nuclear medicine 2019; (44(1)):81-82 doi:10.1097/RLU.0000000000002344.

    PMID: 30371584
  18. 18

    The Usefulness of Muscle Biopsy in Initial Diagnostic Evaluation of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Baek MS, Kim SH, Lee YM

    Yonsei medical journal 2019; (60(1)):98-105 doi:10.3349/ymj.2019.60.1.98.

    PMID: 30554496
  19. 19

    Can Intestinal Pseudo-Obstruction Drive Recurrent Stroke-Like Episodes in Late-Onset MELAS Syndrome? A Case Report and Review of the Literature.

    Gagliardi D, Mauri E, Magri F, et al.

    Frontiers in neurology 2019; (10()):38 doi:10.3389/fneur.2019.00038.

    PMID: 30766507
  20. 20

    A cluster of disseminated small cortical lesions in MELAS: its distinctive clinical and neuroimaging features.

    Hongo Y, Kaneko J, Suga H, et al.

    Journal of neurology 2019; (266(6)):1459-1472 doi:10.1007/s00415-019-09283-3.

    PMID: 30888501
  21. 21

    [Ultrastructural and clinical findings of mitochondrial encephalomyopathy:report of 27 cases].

    Zhang Q, Sun YL, Zhang CP, et al.

    Zhonghua bing li xue za zhi = Chinese journal of pathology 2019; (48(4)):298-302 doi:10.3760/cma.j.issn.0529-5807.2019.04.007.

    PMID: 30955266
  22. 22

    Diagnosis of adult-onset MELAS syndrome in a 63-year-old patient with suspected recurrent strokes - a case report.

    Sinnecker T, Andelova M, Mayr M, et al.

    BMC neurology 2019; (19(1)):91 doi:10.1186/s12883-019-1306-6.

    PMID: 31068171
  23. 23

    Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report.

    Fukuda M, Nagao Y

    Journal of medical case reports 2019; (13(1)):313 doi:10.1186/s13256-019-2255-9.

    PMID: 31630688
  24. 24

    Haemorrhagic Transformation of a MELAS Stroke-Like Lesion.

    Bensaidane MR, Camden MC, Savard M

    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2020; (47(1)):117-118 doi:10.1017/cjn.2019.317.

    PMID: 31648660
  25. 25

    Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes.

    Ikawa M, Povalko N, Koga Y

    Current opinion in clinical nutrition and metabolic care 2020; (23(1)):17-22 doi:10.1097/MCO.0000000000000610.

    PMID: 31693521
  26. 26

    Heteroplasmy and phenotype spectrum of the mitochondrial tRNALeu (UUR) gene m.3243A>G mutation in seven Han Chinese families.

    Liu G, Shen X, Sun Y, et al.

    Journal of the neurological sciences 2020; (408()):116562 doi:10.1016/j.jns.2019.116562.

    PMID: 31722256
  27. 27

    Adult onset MELAS Syndrome Presenting as A Mimic of Herpes Simplex Encephalitis.

    Chen WT, Lin YS, Wang YF, Fuh JL

    Acta neurologica Taiwanica 2019; (28(2)()):46-51.

    PMID: 31867706
  28. 28

    Therapeutic Potential of Citrulline as an Arginine Supplement: A Clinical Pharmacology Review.

    Rashid J, Kumar SS, Job KM, et al.

    Paediatric drugs 2020; (22(3)):279-293 doi:10.1007/s40272-020-00384-5.

    PMID: 32140997
  29. 29

    One mutation, three phenotypes: novel metabolic insights on MELAS, MIDD and myopathy caused by the m.3243A > G mutation.

    Esterhuizen K, Lindeque JZ, Mason S, et al.

    Metabolomics : Official journal of the Metabolomic Society 2021; (17(1)):10 doi:10.1007/s11306-020-01769-w.

    PMID: 33438095
  30. 30

    Circulating markers of NADH-reductive stress correlate with mitochondrial disease severity.

    Sharma R, Reinstadler B, Engelstad K, et al.

    The Journal of clinical investigation 2021; (131(2)).

    PMID: 33463549
  31. 31

    Mitochondrial Myopathy, Encephalopathy, Lactic acidosis and Stroke-Like Episodes Syndrome Presenting With Anton-Babinski Syndrome and Concurrent Occipital Lobe Seizures.

    Ewida A, Ahmed R, Luo A, et al.

    Cureus 2021; (13(1)):e12908 doi:10.7759/cureus.12908.

    PMID: 33654593
  32. 32

    Adult-onset mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) syndrome with progressive sensorineural hearing loss: A case report.

    Trang TM, Chien PC, Dung BT, et al.

    Radiology case reports 2021; (16(7)):1865-1869 doi:10.1016/j.radcr.2021.04.049.

    PMID: 34093932
  33. 33

    Epilepsy Associated With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Li J, Zhang W, Cui Z, et al.

    Frontiers in neurology 2021; (12()):675816 doi:10.3389/fneur.2021.675816.

    PMID: 34177782
  34. 34

    Immunonutrition for the acute treatment of MELAS syndrome.

    Pérez-Cruz E, González-Rivera C, Valencia-Olvera LDCG

    Endocrinologia, diabetes y nutricion 2021; doi:10.1016/j.endinu.2021.03.004.

    PMID: 34210633
  35. 35

    Mitochondrial Strokes: Diagnostic Challenges and Chameleons.

    Pizzamiglio C, Bugiardini E, Macken WL, et al.

    Genes 2021; (12(10)) doi:10.3390/genes12101643.

    PMID: 34681037
  36. 36

    ECMO for Metabolic Crisis in a Patient with Mitochondrial Disease.

    Sharma S, Deerman C, Andreae MH, Myler C

    Case reports in anesthesiology 2021; (2021()):9914311 doi:10.1155/2021/9914311.

    PMID: 34760322
  37. 37

    Clinical Characteristics of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes.

    Fan HC, Lee HF, Yue CT, Chi CS

    Life (Basel, Switzerland) 2021; (11(11)) doi:10.3390/life11111111.

    PMID: 34832987
  38. 38

    Reversal of Stroke-Like Episodes With L-Arginine and Meticulous Perioperative Management of Renal Transplantation in a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome. Case Report.

    Al Yazidi G, Mulder J, Licht C, et al.

    The Neurohospitalist 2022; (12(1)):67-73 doi:10.1177/19418744211000512.

    PMID: 34950389
  39. 39

    Neurological manifestations in m.3243A>G-related disease triggered by metformin.

    Tong HF, Lee HH, Tong TT, et al.

    Journal of diabetes and its complications 2022; (36(3)):108111 doi:10.1016/j.jdiacomp.2021.108111.

    PMID: 35123869
  40. 40

    Cochlear Implantation in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome: Case Presentation.

    Crundwell G, Kullar P, Bance M

    The journal of international advanced otology 2022; (18(1)):71-73 doi:10.5152/iao.2022.21316.

    PMID: 35193849
  41. 41

    Molecular and neurological features of MELAS syndrome in paediatric patients: A case series and review of the literature.

    Seed LM, Dean A, Krishnakumar D, et al.

    Molecular genetics & genomic medicine 2022; (10(7)):e1955 doi:10.1002/mgg3.1955.

    PMID: 35474314
  42. 42

    Modeling Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome Using Patient-Derived Induced Neurons Generated by Direct Reprogramming.

    Povea-Cabello S, Villanueva-Paz M, Villalón-García I, et al.

    Cellular reprogramming 2022; (24(5)):294-303 doi:10.1089/cell.2022.0055.

    PMID: 35802497
  43. 43

    Traumatic Brain Injury Triggers Neurodegeneration in a Mildly Symptomatic MELAS Patient: Implications on the Detrimental Role of Damaged Mitochondria in Determining Head Trauma Sequalae in the General Population.

    Zanotti S, Velardo D, Sciacco M

    Metabolites 2022; (13(1)) doi:10.3390/metabo13010046.

    PMID: 36676971
  44. 44

    Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome: a case report.

    Ru YX, Ying L, Dong SX, et al.

    Ultrastructural pathology 2023; (47(3)):227-235 doi:10.1080/01913123.2023.2184892.

    PMID: 36871223
  45. 45

    Two Patients Diagnosed as Succinate Dehydrogenase Deficiency: Case Report.

    Ürey BC, Ceylan AC, Çavdarlı B, et al.

    Molecular syndromology 2023; (14(2)):171-174 doi:10.1159/000527538.

    PMID: 37064335
  46. 46

    Pearls & Oy-sters: Whole-Genome Sequencing in Critically Ill Neurologic Patient Leads to Diagnosis With Treatment Implications.

    Gaillard JR, Whitt Z, Selwa LM, et al.

    Neurology 2023; (101(13)):588-592 doi:10.1212/WNL.0000000000207552.

    PMID: 37460236
  47. 47

    Droplet digital polymerase chain reaction to measure heteroplasmic m.3243A>G mitochondrial mutations.

    Matsumoto S, Uchiumi T, Noda N, et al.

    Laboratory medicine 2024; (55(2)):227-233 doi:10.1093/labmed/lmad063.

    PMID: 37478467
  48. 48

    Late-onset MELAS syndrome in a 46-year-old man with initial symptom of chest tightness: a case report.

    Wang A, Zhao J, Zhao Y, Yan Y

    European heart journal. Case reports 2023; (7(9)):ytad441 doi:10.1093/ehjcr/ytad441.

    PMID: 37767231
  49. 49

    A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS.

    Shin HJ, Na JH, Lee YM

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2024; (45(5)):2337-2339 doi:10.1007/s10072-024-07343-9.

    PMID: 38265537
  50. 50

    Gastrointestinal Complications of Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome Managed By Parenteral Nutrition.

    Horná S, Péč MJ, Krivuš J, et al.

    European journal of case reports in internal medicine 2024; (11(2)):004268 doi:10.12890/2024_004268.

    PMID: 38352812
  51. 51

    Adult-onset mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): a diagnostic challenge.

    Acquaah J, Ferdinand P, Roffe C

    BMJ case reports 2024; (17(2)) doi:10.1136/bcr-2023-256306.

    PMID: 38413140
  52. 52

    A Case Report of a Clinically Suspected Diagnosis of Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome With Cardiac Impairment.

    Momoh R, Kollamparambil S

    Cureus 2024; (16(3)):e56980 doi:10.7759/cureus.56980.

    PMID: 38665734
  53. 53

    Neovascular Glaucoma in MELAS syndrome.

    Khanna S, Smith BT

    American journal of ophthalmology case reports 2024; (34()):102064 doi:10.1016/j.ajoc.2024.102064.

    PMID: 38707951
  54. 54

    Case report: Late-onset MELAS syndrome with mtDNA 5783G>A mutation diagnosed by urinary sediment genetic testing.

    Cai H, Li LM, Zhang M, et al.

    Frontiers in genetics 2024; (15()):1367716 doi:10.3389/fgene.2024.1367716.

    PMID: 38881794
  55. 55

    Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes with coexisting nemaline myopathy: a case report.

    Gunawardena K, Praveenan S, Dissanayake VHW, Ratnayake P

    Journal of medical case reports 2024; (18(1)):420 doi:10.1186/s13256-024-04723-9.

    PMID: 39252049
  56. 56

    Efficacy of a mitochondrial drug cocktail in preventing acute encephalopathy with biphasic seizures and late reduced diffusion.

    Omata T, Aoyama H, Murayama K, et al.

    Journal of the neurological sciences 2024; (466()):123245 doi:10.1016/j.jns.2024.123245.

    PMID: 39303350
  57. 57

    A case with short stature and proteinuria: atypical presentation of a family with m.3243A>G mutation.

    Büyükyılmaz G, İnözü M, Çavdarlı B

    The Turkish journal of pediatrics 2024; (66(4)):490-498 doi:10.24953/turkjpediatr.2024.4702.

    PMID: 39387423
  58. 58

    Effective Management of Chronic Intestinal Pseudo-Obstruction in MELAS Using Acotiamide: A Case Report.

    Kawano Y, Taniguchi A, Narita Y, et al.

    Case reports in neurology 2024; (16(1)):288-293 doi:10.1159/000541012.

    PMID: 39544351
  59. 59

    Segmental and Focal Glomerulosclerosis Secondary to MELAS Syndrome and Long-Term Outcomes After Kidney Transplant: Case Report and Literature Review.

    de Sousa MV, Mariani G, Ribeiro Alves MAVF, Mazzali M

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2025; (23(2)):146-150 doi:10.6002/ect.2025.0006.

    PMID: 40094257
  60. 60

    Clinical characteristics and long-term prognosis of 150 children with MELAS syndrome in China.

    Xu C, Dai S, Jiang H, et al.

    Journal of neurology 2025; (272(4)):280 doi:10.1007/s00415-025-13009-z.

    PMID: 40119058
  61. 61

    Acute Management of Neurological Events in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome: A Case Report.

    Aladashvili Z, Rodriguez TB, Izquierdo-Pretel G

    Cureus 2025; (17(5)):e83959 doi:10.7759/cureus.83959.

    PMID: 40502899
  62. 62

    Diagnosing Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-Like Episodes (MELAS) Syndrome in a Young Adult Female Patient With Seizures and Lactic Acidosis.

    Sane IA, Gupte JR

    Cureus 2025; (17(7)):e88031 doi:10.7759/cureus.88031.

    PMID: 40821128
  63. 63

    Retinal multimodal-imaging and functional tests in a mitochondrial disease with focal and segmental glomerulosclerosis.

    Liu XH, Shen X, Zhong YS

    International journal of ophthalmology 2025; (18(9)):1770-1776 doi:10.18240/ijo.2025.09.19.

    PMID: 40881443
  64. 64

    Outcomes misaligned in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): implications for trial design.

    Stefanetti RJ, Charman SJ, Newman J, et al.

    Brain communications 2025; (7(5)):fcaf342 doi:10.1093/braincomms/fcaf342.

    PMID: 41048545
  65. 65

    Safe Use of Metformin in Mitochondrial Diabetes in Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes: Insights From a Patient With m.3243A>G Mutation.

    Santhosh T, Ramamurthy P, Simha V

    AACE endocrinology and diabetes 2025; (12(3)):150-152 doi:10.1016/j.aed.2025.07.001.

    PMID: 41048693
  66. 66

    Multiparametric MRI detection of cerebral metabolism: a tool for early differentiation between MELAS and ischemic cerebral infarction.

    Yang X, Xu Y, Zhang S, et al.

    Quantitative imaging in medicine and surgery 2025; (15(10)):9466-9478 doi:10.21037/qims-24-2396.

    PMID: 41081123
  67. 67

    Atypical clinical manifestation of MT-TL1 mutation in 6 months old patient.

    Janiak J, Piątkowska W, Podlejska P, et al.

    Acta neurologica Belgica 2025; doi:10.1007/s13760-025-02921-w.

    PMID: 41171526
  68. 68

    Mitochondrial DNA A3243G variant: Current perspectives and clinical implications.

    Chu KY

    Intractable & rare diseases research 2025; (14(4)):249-257 doi:10.5582/irdr.2025.01051.

    PMID: 41341917
  69. 69

    Basic Science and Pathogenesis.

    Mutyala S, Maali LN, Pasya SK

    Alzheimer's & dementia : the journal of the Alzheimer's Association 2025; (21 Suppl 1()):e106536 doi:10.1002/alz70855_106536.

    PMID: 41443978
  70. 70

    Approach to the Patient - Mitochondrial Diabetes: Contemporary Cases and Precision Medicine Approach.

    Oppenheimer KR, Himelhoch NT, McCullough ME, et al.

    The Journal of clinical endocrinology and metabolism 2025; doi:10.1210/clinem/dgaf698.

    PMID: 41472381
  71. 71

    Fahr Syndrome, Hypoparathyroidism and Mitochondrial Encephalomyopathy With Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome.

    Li J, Wang X, Guo Y, et al.

    AACE endocrinology and diabetes 2026; (13(1)):102-106 doi:10.1016/j.aed.2025.09.007.

    PMID: 41641297
  72. 72

    A novel tRNASer(AGY) 12244G > a variant impairs mitochondrial function and presents with classical MELAS phenotype.

    Zhuang X, Wang J, Wang J, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(3)):264 doi:10.1007/s10072-026-08875-y.

    PMID: 41692888